New patent for the drug Altathera Pharms SOTALOL HYDROCHLORIDE – DrugPatentWatch
Expired Annual Drug Patent for SOTALOL+HYDROCHLORIDE
Sotalol Hydrochloride is a drug marketed by Altathera Pharms Llc, Apotex, Aurobindo Pharma Usa, Beximco Pharms Usa, Epic Pharma Inc, Impax Pharms, Mylan, Oxford Pharms, Sun Pharm Industries, Teva, Upsher Smith Labs, and Watson Labs and, and includes in seventeen NDAs. It is available from seventeen suppliers. There are two patents protecting this drug.
Drug patent litigation for SOTALOL HYDROCHLORIDE.
The generic ingredient in SOTALOL HYDROCHLORIDE is sotalol hydrochloride. Seventeen registered suppliers for this complex. Additional details are available on the sotalol hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for Altathera Pharms drug SOTALOL HYDROCHLORIDE